Jbf Capital, Inc. Aptevo Therapeutics Inc. Transaction History

Jbf Capital, Inc.

  • $630 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$6.48 - $17.49 $25,317 - $68,333
-3,907 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$27.86 - $40.59 $36,218 - $52,767
1,300 Added 49.87%
3,907 $119,000
Q4 2020

Feb 11, 2021
BUY
$6.21 - $48.36 $16,189 - $126,074
2,607 New
2,607 $96,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.5M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Jbf Capital, Inc. Portfolio

Follow Jbf Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jbf Capital, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email